Therapeutics: News and Research on Punctures

MeSH tree: E02.800

FDA approves first-in-class drug for polycythemia vera

The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals' Mimrylo (rusfertide) as a new treatment for adults with polycythemia vera who have not achieved adequate control with existing therapies.

page 1 from 2